Westminster, CA – November 15, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Wednesday, November 17, 2021, at 8:00 am PST / 11:00 am EST. The webcast and conference call, which is open to the public, will be held to review the company’s financial results, discuss recent commercial milestones, and conduct a question-and-answer session.
The webcast and teleconference
replay will be made available on the
Investor Relations section of BioLargo’s website at biolargo.com/investor-relations. To listen to a live broadcast, go to the site at least 15
minutes prior to the scheduled start time to register, download, and install
any necessary audio video software.
To participate in the live webcast and teleconference:
|
Webcast Link: |
|
|
Teleconference Domestic: |
888-506-0062 |
|
Teleconference International: |
973-528-0011 |
To watch or listen to a
replay of the webcast or teleconference:
|
Webcast Replay Expiration: |
Wednesday, November
16, 2022 |
|
Teleconference Replay Expiration: |
Tuesday, December 1, 2022 |
|
Teleconference Replay Domestic: |
877-481-4010 |
|
Teleconference Replay International: |
919-882-2331 |
|
Replay Passcode: |
43712 |
BioLargo,
Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform
technologies to solve challenging environmental problems like PFAS
contamination, advanced water and wastewater treatment, industrial odor and VOC
control, air quality control, and infection control. With over 13 years of
extensive R&D, BioLargo holds a wide array of issued patents, maintains a
robust pipeline of products, and provides full-service environmental
engineering. Our peer-reviewed scientific approach allows us to invent or
acquire novel technologies and develop them to maturity through our operating
subsidiaries. With a keen emphasis on collaborations with academic, municipal,
and commercial organizations and associations, BioLargo has proven itself with
over 80 awarded grants and numerous pilot projects. We monetize through direct
sales, recurring service contracts, licensing agreements, strategic joint
venture formation and/or the sale of the IP. See our website at www.BioLargo.com.
Contact
Information
Dennis
P. Calvert
President
and CEO, BioLargo, Inc.
888-400-2863
Safe
Harbor Act
This press
release contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking statements
include without limitation those about BioLargo’s (the “Company”) expectations
regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans
for future operations. These statements involve risks and uncertainties, and
actual results may differ materially from any future results expressed or
implied by the forward-looking statements. Risks and uncertainties include
without limitation: the effect of the COVID-19 pandemic on the Company’s
business, results of operations, financial condition, and stock price; the
effect of regional economic conditions on the Company’s business, including
effects on purchasing decisions by consumers and businesses; the ability of the
Company to compete in markets that are highly competitive and subject to rapid
technological change; the ability of the Company to manage frequent
introductions and transitions of products and services, including delivering to
the marketplace, and stimulating customer demand for, new products, services,
and technological innovations on a timely basis; the dependency of the Company
on the performance of distributors of the Company’s products. More information
on these risks and other potential factors that could affect the Company’s
business and financial results is included in the Company’s filings with the
SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” sections of the Company’s
most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent
filings. The Company assumes no obligation to update any forward-looking
statements or information, which speak as of their respective dates.
No comments:
Post a Comment